JP2010514798A5 - - Google Patents

Download PDF

Info

Publication number
JP2010514798A5
JP2010514798A5 JP2009544280A JP2009544280A JP2010514798A5 JP 2010514798 A5 JP2010514798 A5 JP 2010514798A5 JP 2009544280 A JP2009544280 A JP 2009544280A JP 2009544280 A JP2009544280 A JP 2009544280A JP 2010514798 A5 JP2010514798 A5 JP 2010514798A5
Authority
JP
Japan
Prior art keywords
groups
npl
polar
substituted
nonpolar
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009544280A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010514798A (ja
JP5512279B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/089001 external-priority patent/WO2008083256A2/en
Publication of JP2010514798A publication Critical patent/JP2010514798A/ja
Publication of JP2010514798A5 publication Critical patent/JP2010514798A5/ja
Application granted granted Critical
Publication of JP5512279B2 publication Critical patent/JP5512279B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009544280A 2006-12-29 2007-12-28 面状両親媒性ポリマー及びオリゴマーの眼科用及び耳科用組成物とその使用 Expired - Fee Related JP5512279B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88280006P 2006-12-29 2006-12-29
US60/882,800 2006-12-29
PCT/US2007/089001 WO2008083256A2 (en) 2006-12-29 2007-12-28 Ophthalmic and otic compositions of facially amphiphilic polymers and oligomers and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014061503A Division JP5745666B2 (ja) 2006-12-29 2014-03-25 面状両親媒性ポリマー及びオリゴマーの眼科用及び耳科用組成物とその使用

Publications (3)

Publication Number Publication Date
JP2010514798A JP2010514798A (ja) 2010-05-06
JP2010514798A5 true JP2010514798A5 (https=) 2010-09-16
JP5512279B2 JP5512279B2 (ja) 2014-06-04

Family

ID=39589209

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009544280A Expired - Fee Related JP5512279B2 (ja) 2006-12-29 2007-12-28 面状両親媒性ポリマー及びオリゴマーの眼科用及び耳科用組成物とその使用
JP2014061503A Expired - Fee Related JP5745666B2 (ja) 2006-12-29 2014-03-25 面状両親媒性ポリマー及びオリゴマーの眼科用及び耳科用組成物とその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014061503A Expired - Fee Related JP5745666B2 (ja) 2006-12-29 2014-03-25 面状両親媒性ポリマー及びオリゴマーの眼科用及び耳科用組成物とその使用

Country Status (12)

Country Link
US (5) US20090092574A1 (https=)
EP (1) EP2114395B1 (https=)
JP (2) JP5512279B2 (https=)
CN (3) CN102342941A (https=)
AU (1) AU2007339790B2 (https=)
CA (1) CA2674080C (https=)
DK (1) DK2114395T3 (https=)
ES (1) ES2538479T3 (https=)
HU (1) HUE025868T2 (https=)
PL (1) PL2114395T3 (https=)
PT (1) PT2114395E (https=)
WO (1) WO2008083256A2 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070207211A1 (en) * 2003-04-10 2007-09-06 Pr Pharmaceuticals, Inc. Emulsion-based microparticles and methods for the production thereof
US20090092574A1 (en) 2006-12-29 2009-04-09 Scott Richard W Ophthalmic And Otic Compositions Of Facially Amphiphilic Polymers And Oligomers And Uses Thereof
RU2530899C2 (ru) * 2008-07-28 2014-10-20 Селлсьютикс Корпорейшн Противомалярийные соединения
TWI478915B (zh) * 2008-10-27 2015-04-01 Cellceutix Corp 宿主防禦之合成模擬物及其用途
ITTO20090131A1 (it) * 2009-02-24 2010-08-25 Liofarmaceutici Srl Composizioni oftalmiche contenenti teicoplanina
CA2804666A1 (en) * 2010-07-07 2012-01-12 Polymedix, Inc. Methods of immune modulation
US20120190653A1 (en) * 2011-01-20 2012-07-26 Dow Pharmaceutical Sciences, Inc. Therapeutic eye drop comprising doxycycline and a stabilizer
EP2709619B1 (en) * 2011-05-16 2017-10-11 Cellceutix Corporation Compounds for use in treatment of mucositis
TW202023575A (zh) * 2011-09-16 2020-07-01 美商遠景生物製藥股份有限公司 安定之普維酮—碘組成物
MX2014008763A (es) * 2012-01-18 2015-04-13 Cellceutix Corp Compuestos y metodos para tratar infecciones por candidosis y aspergillus.
US20150164882A1 (en) 2013-07-22 2015-06-18 Imprimis Pharmaceuticals, Inc. Pharmaceutical compositions for intraocular administration and methods for fabricating thereof
JP6047203B2 (ja) * 2015-02-20 2016-12-21 セルセウティックス コーポレイション 消化管の炎症性疾患の予防および／または治療のための宿主防御タンパク質（ｈｄｐ）模倣薬
CN108350395A (zh) 2015-09-03 2018-07-31 杜兰教育基金委员会 多用途消毒和灭菌溶液的组合物和方法
EP3478654A4 (en) * 2016-07-01 2020-02-26 Boulos&Cooper Pharmaceuticals PTY Ltd NEW ANTIBIOTICS
IT201900000561A1 (it) * 2019-01-14 2020-07-14 Medivis S R L Formulazioni topiche oftalmiche chimicamente e fisicamente stabili a base di Nepafenac
WO2021248008A1 (en) 2020-06-05 2021-12-09 Innovation Pharmaceuticals Inc. Arylamide compounds for treatment and prevention of viral infections
JP2024506384A (ja) 2021-02-10 2024-02-13 イオリクス セラピューティクス，インコーポレーテッド ロフルミラストの眼科的送達方法
CA3231766A1 (en) 2021-09-22 2023-03-30 Elizabeth W. JEFFORDS Methods of treating ocular inflammatory diseases

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3496179A (en) * 1967-10-11 1970-02-17 Pfizer & Co C 2-amino-3,4-dihydroquinazolines
SE352811B (https=) 1971-06-04 1973-01-15 Pharmacia Ab
US3960150A (en) 1971-09-09 1976-06-01 Alza Corporation Bioerodible ocular device
US3867519A (en) 1972-04-27 1975-02-18 Alza Corp Bioerodible drug delivery device
SE375007B (https=) 1972-11-30 1975-04-07 Pharmacia Ab
US3914402A (en) 1973-06-14 1975-10-21 Alza Corp Ophthalmic dosage form, for releasing medication over time
US3963025A (en) 1974-09-16 1976-06-15 Alza Corporation Ocular drug delivery device
US4186184A (en) 1977-12-27 1980-01-29 Alza Corporation Selective administration of drug with ocular therapeutic system
US4303637A (en) 1980-04-04 1981-12-01 Alza Corporation Medication indicated for ocular hypertension
US4559343A (en) 1982-09-07 1985-12-17 Alcon Laboratories, Inc. Nonirritating aqueous ophthalmic compositions comfort formulation for ocular therapeutic agents
US5223492A (en) 1987-10-27 1993-06-29 Nasraoui Nejib M Derivatives of 19-nor progesterone; process for producing them and the pharmaceutical compositions incorporating them
US5190927A (en) 1991-07-09 1993-03-02 Merck & Co., Inc. High-glyceryl, low-acetyl gellan gum for non-brittle gels
DK0629347T3 (da) * 1992-01-23 1998-02-16 Morinaga Milk Industry Co Ltd Antibakterielt middel og behandling af genstande dermed
US5443505A (en) 1993-11-15 1995-08-22 Oculex Pharmaceuticals, Inc. Biocompatible ocular implants
FI970706A7 (fi) 1994-08-30 1997-04-07 Pharmacia Ab Laite okulaarin käsittelemiseksi
US5869079A (en) 1995-06-02 1999-02-09 Oculex Pharmaceuticals, Inc. Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
US6025326A (en) 1995-07-07 2000-02-15 Intrabiotics Pharmaceuticals, Inc. Compositions and methods for the prevention and treatment of oral mucositis
US5994306A (en) 1995-11-22 1999-11-30 Intrabiotics Pharmaceuticals, Inc. Fine-tuned protegrins
JP3090125B2 (ja) * 1997-08-26 2000-09-18 千寿製薬株式会社 ソフトコンタクトレンズ用の眼科用組成物、ソフトコンタクトレンズの濡れ増強方法およびテルペノイドの吸着抑制方法
DE69907476T2 (de) * 1998-08-20 2004-04-15 The University Of North Carolina At Chapel Hill Office Of Technology Development Dibenzothiophene derivate und ihre verwendung
US20040152664A1 (en) * 1998-09-02 2004-08-05 Allergan, Inc. Prednisolone compositions
US6482799B1 (en) * 1999-05-25 2002-11-19 The Regents Of The University Of California Self-preserving multipurpose ophthalmic solutions incorporating a polypeptide antimicrobial
JP2001261674A (ja) * 2000-03-22 2001-09-26 Mitsui Chemicals Inc ベンゾチオフェン誘導体およびそれを有効成分として含有する核内レセプター作動薬
FR2813080B1 (fr) * 2000-08-17 2002-11-29 Stago Diagnostica Peptides anti-heparine
EP3045168A1 (en) * 2000-11-08 2016-07-20 FXS Ventures, LLC Improved ophthalmic and contact lens solution
US6955806B2 (en) 2001-01-18 2005-10-18 Genzyme Corporation Ionene polymers and their use as antimicrobial agents
EP2289524A1 (en) * 2001-03-08 2011-03-02 The Trustees Of The University Of Pennsylvania Facially amphiphillic polymers as anti-infective agents
AR034372A1 (es) * 2001-06-08 2004-02-18 Novartis Ag Composiciones farmaceuticas
WO2003024391A2 (en) 2001-08-16 2003-03-27 Mucosal Therapeutics, Inc. Treatment and prevention of mucositis in cancer patients
CA2487454A1 (en) * 2002-05-28 2003-12-04 The Trustees Of The University Of Pennsylvania Methods, systems, and computer program products for computational analysis and design of amphiphilic polymers
EP1513622A4 (en) * 2002-06-13 2005-09-14 Univ Pennsylvania METHODS, SYSTEMS AND COMPUTER PROGRAM PRODUCTS FOR STIMULATING BIOMEMBRANES USING ROUGH GRAIN MODELS
WO2004046109A2 (en) 2002-11-19 2004-06-03 Genzyme Corporation Ionene oligomers and polymers
EP2471526A3 (en) * 2003-03-17 2012-12-12 The Trustees Of The University Of Pennsylvania Facially amphiphillic polymers and oligomers and uses thereof
AU2003249114A1 (en) 2003-03-20 2004-10-11 Shiseido International France Cosmetic composition
US20040202687A1 (en) * 2003-04-14 2004-10-14 Babu M.K. Manoj Ciprofloxacin formulations and methods of making and using the same
US20050065091A1 (en) * 2003-09-18 2005-03-24 Gholam Peyman Stabilized ocular solutions
CN1922133A (zh) * 2004-01-23 2007-02-28 宾夕法尼亚州大学理事会 表面两亲性聚芳基和聚芳基炔基聚合物和低聚物及其用途
AU2005254574B2 (en) 2004-06-15 2012-02-02 Polymedix, Inc. Polycationic compounds and uses thereof
JP5027659B2 (ja) * 2004-07-23 2012-09-19 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア 抗菌コポリマーおよびその使用
US20060241052A1 (en) * 2005-02-25 2006-10-26 Degrado William F Facially amphiphilic polymers and oligomers, compositions thereof, and use thereof in methods of treating cancer
ES2351665T3 (es) 2005-03-24 2011-02-09 Rottapharm S.P.A. Derivados de benzamidina para el tratamiento y la prevención de mucositis.
WO2006122162A2 (en) 2005-05-10 2006-11-16 The University Of Chicago Use of peptides derived from the growth factor amp-18 for the treatment of mucositis
US7951829B2 (en) 2006-05-03 2011-05-31 Janssen Pharmaceutica Nv Benzimidazole modulators of VR1
JP2008137978A (ja) * 2006-12-05 2008-06-19 Canon Inc カルバゾール誘導体及びこれを用いた有機発光素子
US20090092574A1 (en) 2006-12-29 2009-04-09 Scott Richard W Ophthalmic And Otic Compositions Of Facially Amphiphilic Polymers And Oligomers And Uses Thereof
WO2009061697A1 (en) 2007-11-09 2009-05-14 The Board Of Trustees Of The University Of Illinois Anticoagulant antagonist and hemophilia procoagulant
RU2530899C2 (ru) 2008-07-28 2014-10-20 Селлсьютикс Корпорейшн Противомалярийные соединения
TWI478915B (zh) * 2008-10-27 2015-04-01 Cellceutix Corp 宿主防禦之合成模擬物及其用途
CA2746421A1 (en) 2008-12-10 2010-06-17 Polymedix, Inc. Antimicrobial molecules for treating multi-drug resistant and extensively drug resistant strains of mycobacterium
UA110323C2 (en) 2009-06-04 2015-12-25 Promedior Inc Derivative of serum amyloid p and their receipt and application
MX2012007662A (es) * 2010-01-07 2012-08-23 Polymedix Inc Compuestos anti-heparina.
TW201208677A (en) 2010-08-21 2012-03-01 Polymedix Inc Facially amphiphilic compounds, compositions, and uses thereof in treating cancer
EP2709619B1 (en) 2011-05-16 2017-10-11 Cellceutix Corporation Compounds for use in treatment of mucositis
MX2014008763A (es) 2012-01-18 2015-04-13 Cellceutix Corp Compuestos y metodos para tratar infecciones por candidosis y aspergillus.
US20140171438A1 (en) 2012-12-10 2014-06-19 Cellceutix Corporation Hybrid Compounds And Methods Of Making And Using The Same
US20140308317A1 (en) 2012-12-10 2014-10-16 Cellceutix Corporation Polymeric Compounds And Methods Of Making And Using The Same
RU2675847C2 (ru) 2013-05-28 2018-12-25 Морфохем Акциенгезельшафт Фюр Комбинаторише Хеми Комбинированные терапевтические средства, содержащие оксазолидинон-хинолоны, предназначенные для лечения бактериальных инфекций
JP6047203B2 (ja) 2015-02-20 2016-12-21 セルセウティックス コーポレイション 消化管の炎症性疾患の予防および／または治療のための宿主防御タンパク質（ｈｄｐ）模倣薬

Similar Documents

Publication Publication Date Title
JP2010514798A5 (https=)
CA2674080C (en) Ophthalmic and otic compositions of facially amphiphilic polymers and oligomers and uses thereof
WO2007108541A1 (ja) キサンタンガムおよびブドウ糖を含有する眼科用組成物
JP2002525317A5 (https=)
JP2006521355A5 (https=)
JP2012520882A5 (https=)
US20030055051A1 (en) Ophthalmic aqueous pharmaceutical preparation
US11890375B2 (en) Ophthalmic solution of difluprednate
CA2660151A1 (en) Compositions and methods for treating, controlling, reducing, or ameliorating infections and sequelae thereof
JP5925823B2 (ja) ヒアルロン酸又はその薬学的に許容される塩を含む保存組成物及び関連する方法
WO2010150812A1 (ja) 眼科用組成物及び白濁・沈殿抑制方法
JP2008531585A5 (https=)
JP4725699B2 (ja) 眼科用組成物及び眼科用組成物配合用防腐剤
KR20170093816A (ko) 녹내장을 예방 또는 치료하기 위한 약물 요법
JPWO2015125921A1 (ja) 保存効力を有する医薬用水性組成物
EP1876175B1 (en) Therapeutic agent for corneal disease
JP4470393B2 (ja) 安定である点眼剤
AU2013242820A1 (en) Ophthalmic and otic compositions of facially amphiphilic polymers and oligomers and uses thereof